Yujuan H. Guan

627 Dongfeng Dong Rd
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Evaluation of pegylated interferon-α therapy efficacy in patients with inactive hepatitis B surface antigen carrier state.

Evaluation of pegylated interferon-α therapy efficacy in patients with inactive hepatitis B surface antigen carrier state.

Journal: Scandinavian journal of gastroenterology

Published: April 01, 2026

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Journal: American journal of hematology

Published: March 20, 2026

Chinese Guidelines for Clinical Diagnosis, Treatment, and Management of Cirrhosis (2025).

Chinese Guidelines for Clinical Diagnosis, Treatment, and Management of Cirrhosis (2025).

Journal: Journal of clinical and translational hepatology

Published: October 05, 2025

Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.

Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.

Journal: Journal of viral hepatitis

Published: May 15, 2025

Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis.

Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis.

Journal: Journal of clinical and translational hepatology

Published: March 06, 2025

Peginterferon α-2b Enhances Hepatitis B Surface Antigen Loss in Nucleos(t)ide Analogue-Suppressed Low Hepatitis B Surface Antigen Chronic Hepatitis B Patients: Everest Study in China.

Peginterferon α-2b Enhances Hepatitis B Surface Antigen Loss in Nucleos(t)ide Analogue-Suppressed Low Hepatitis B Surface Antigen Chronic Hepatitis B Patients: Everest Study in China.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: February 19, 2025

Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma.

Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 22, 2024

Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024).

Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024).

Journal: Journal of clinical and translational hepatology

Published: December 18, 2024

Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection.

Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection.

Journal: Journal of clinical and translational hepatology

Published: August 29, 2024

A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma.

A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma.

Journal: Discover oncology

Published: July 19, 2024

Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.

Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.

Journal: Infectious diseases and therapy

Published: July 17, 2023

DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.

DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.

Journal: Journal of virology

Published: July 21, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026